Qualidade das evidências 4.75/5
Pontuação de revisão em oito dimensões segundo a grelha de qualidade . Cada dimensão pontuada de 1 a 5.
- D1 Ancoragem nas fontes
- 4/5
- D2 Autoridade das fontes
- 5/5
- D3 Aritmética
- 5/5
- D4 Incerteza
- 4/5
- D5 Âmbito
- 5/5
- D6 Prosa
- 5/5
- D7 Honestidade sobre a perceção
- 5/5
- D8 Completude das ressalvas
- 5/5
Como o risco varia
O valor principal é uma média de situações muito diferentes. Veja como a probabilidade varia por cenário ou contexto:
—
At 200–400 mg aspartame/day, exposure is 7–14% of the ADI. No regulatory body identifies measurable cancer risk at this level.
—
At 800+ mg/day, still below half the ADI for a 70 kg adult. No cohort data shows dose-response at this range; Debras et al. grouped all above-median consumers together.
—
Saccharin was delisted as a carcinogen by the NTP in 2000 after the rat-bladder mechanism was shown to be species-specific. FDA, EFSA, and JECFA all consider saccharin safe at approved levels.
—
Sucralose has not been classified by IARC. FDA approved it in 1998; no large cohort study has linked it to cancer in humans at dietary exposure levels.
O comprimento e o tom da barra classificam estes cenários entre si, não em relação a outros riscos. As probabilidades exatas são mostradas ao lado de cada um.
Em julho de 2023, a IARC classificou o aspartame como Grupo 2B — “possivelmente carcinogênico para humanos” — e as manchetes se escreveram sozinhas. O que a maioria da cobertura omitiu: no mesmo dia, o JECFA reafirmou a ingestão diária aceitável existente de 40 mg/kg/dia, não encontrando razão para alterá-la. Um adulto de 70 kg precisaria de aproximadamente 14 latas de refrigerante diet diariamente para atingir esse limite. A única coorte que impulsionou a classificação, Debras et al. 2022, relatou uma razão de risco de 1,13 para consumidores acima da mediana versus não consumidores — um efeito modesto cujo limite inferior de confiança mal exclui 1,0, proveniente de um estudo observacional com dados dietéticos autorrelatados e sem replicação. A FDA, a EFSA e o JECFA mantêm que o aspartame é seguro nos níveis de consumo atuais.
O padrão é familiar. A sacarina foi proibida no Canadá em 1977 e quase proibida nos EUA depois que estudos encontraram tumores na bexiga em ratos. Duas décadas depois, o mecanismo revelou-se espécie-específico: ratos machos produzem uma proteína que se liga aos metabólitos da sacarina na urina e irrita o epitélio da bexiga. Humanos não produzem essa proteína. O NTP retirou a sacarina da lista de carcinógenos em 2000. A categoria Grupo 2B da IARC contém mais de 300 agentes — incluindo extrato de folha inteira de aloe vera, vegetais em conserva e exposição ocupacional como bombeiro — e sinaliza “evidência limitada, vale a pena observar”, não “isso causa câncer na dose em sua mesa de café da manhã.”
Nenhum órgão regulador em qualquer lugar do mundo quantificou uma probabilidade de câncer atribuível ao consumo de adoçantes artificiais em níveis aprovados. A lacuna entre a percepção pública e o consenso regulatório é gritante: consumidores evitam refrigerantes diet por medo de câncer enquanto três agências independentes (FDA, EFSA, JECFA), revisando as mesmas evidências, concluem que o risco atribuível não é distinguível de zero na ingestão normal. Isso não significa que pesquisas futuras não possam mudar o cenário — significa que a evidência atual não sustenta um número, e publicar um seria uma fabricação disfarçada de quantificação.
Curiosidades relacionadas
Não há estimativa confiável que ligue os adoçantes aprovados ao câncer em consumo normal. Revisões regulatórias e grandes estudos de coorte não estabeleceram efeito causal, então não publicamos número algum em vez de inventá-lo.
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
1/6 fontes verificadas de forma independente palavra por palavra em relação à fonte citada
-
[1] International Agency for Research on Cancer (WHO) — Summary of Results — IARC Monographs Volume 134: Aspartame
Summary of Results — IARC Monographs Volume 134: Aspartame- Estatística
Aspartame classified as Group 2B (possibly carcinogenic to humans) based on limited evidence in humans and less than sufficient evidence in experimental animals- Trecho
“"The working group classified aspartame as possibly carcinogenic to humans (Group 2B) based on limited evidence for cancer in humans (for hepatocellular carcinoma," ”
- Dados da fonte de
- 2023-07-14
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- IARC's Group 2B is the third of four levels and indicates limited evidence in humans plus less than sufficient evidence in animals — it is a hazard-identification classification, not a risk quantification. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and radio-frequency electromagnetic fields. The classification does not estimate the probability of cancer at any exposure level, and IARC explicitly noted that the evidence came primarily from a single cohort (NutriNet-Santé) with effect sizes that were borderline after correction for multiple comparisons.
-
[2] World Health Organization / Joint FAO/WHO Expert Committee on Food Additives (JECFA) — Aspartame hazard and risk assessment results released Verificado
Aspartame hazard and risk assessment results released- Estatística
JECFA reaffirmed the existing ADI of 0–40 mg/kg body weight/day, finding no convincing evidence of harm at current consumption levels- Trecho
“"JECFA concluded that the data evaluated indicated no sufficient reason to change the previously established acceptable daily intake (ADI) of 0-40 mg/kg body weight for aspartame." ”
- Dados da fonte de
- 2023-07-14
- Acessado
- 2026-04-18 · cópia arquivada
- Verificação
- Trecho obtido novamente de forma independente e confirmado palavra por palavra em relação à fonte citada durante nossa auditoria de fundamentação.
- Cálculo
- JECFA's evaluation was released simultaneously with IARC's classification. For a 70 kg adult, the ADI of 40 mg/kg/day equals 2,800 mg/day. A 355 ml (12 oz) can of diet soda contains roughly 200 mg of aspartame. Reaching the ADI would require consuming approximately 14 cans per day — a level well beyond typical consumption of 1–2 cans. JECFA and IARC used different frameworks: IARC identifies hazard (can it cause cancer under any conditions?), JECFA assesses risk (does it cause cancer at actual human exposure levels?). The divergence is methodological, not contradictory.
-
[3] PLoS Medicine / Debras et al. — Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study
Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study- Estatística
Higher consumers of artificial sweeteners (above median) had HR 1.13 (95% CI 1.03–1.25) for overall cancer risk vs non-consumers- Trecho
“"Compared to non-consumers, higher consumers of total artificial sweeteners (i.e., above the median exposure in consumers) had higher risk of overall cancer (n = 3,358 cases, hazard ratio [HR] = 1.13 [95% CI 1.03 to 1.25], P-trend = 0.002)." ”
- Dados da fonte de
- 2022-03-24
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- Debras et al. followed 102,865 adults from the French NutriNet-Santé cohort (2009–2021). The reported HR of 1.13 is modest and the lower confidence bound (1.03) barely excludes 1.0. The study is observational with self-reported dietary intake, subject to residual confounding (diet-soda consumers may differ systematically from non-consumers). This is the primary human study cited by IARC for the 2B classification. No prior large cohort has replicated the finding. The authors themselves note the result warrants replication and does not establish causation.
-
[4] U.S. Food and Drug Administration — Aspartame and Other Sweeteners in Food
Aspartame and Other Sweeteners in Food- Estatística
FDA does not agree with IARC's conclusion that aspartame is a possible carcinogen; FDA considers aspartame safe at current approved levels- Trecho
“"FDA disagrees with IARC’s conclusion that these studies support classifying aspartame as a possible carcinogen to humans. … FDA scientists do not have safety concerns when aspartame is used under the approved conditions." ”
- Dados da fonte de
- 2023-07-14
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- FDA's position reflects its own review of the same evidence considered by IARC, including the Ramazzini Institute animal studies (which FDA found methodologically flawed) and the NutriNet-Santé cohort. FDA has approved aspartame since 1981 and has reviewed its safety multiple times. The FDA ADI is 50 mg/kg/day — higher than JECFA's 40 mg/kg/day — reflecting an independent risk assessment reaching a similar conclusion of safety at normal consumption.
-
[5] European Food Safety Authority (EFSA) — Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive
Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive- Estatística
EFSA concluded aspartame and its breakdown products are safe for general population at current exposure levels, setting ADI at 40 mg/kg/day- Trecho
“"The Panel concluded that aspartame was not of safety concern at the current aspartame exposure estimates or at the ADI of 40 mg/kg bw/day." ”
- Dados da fonte de
- 2013-12-10
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- EFSA's 2013 opinion was the most comprehensive regulatory review of aspartame to date, examining over 600 datasets. EFSA found no evidence of genotoxicity or carcinogenicity at doses below the ADI. Actual European population exposure was estimated at 2.8–10 mg/kg/day in high consumers — well below the ADI. This review predates the Debras et al. 2022 study but remains the benchmark regulatory assessment, and EFSA has not revised it following the IARC 2B classification.
-
[6] Wikipedia — Saccharin
Saccharin- Estatística
In 1977 the FDA attempted to completely ban saccharin after rat studies showed bladder tumors, but the ban was blocked by public opposition; Canada separately banned it as a food additive around the same time before later lifting that ban- Trecho
“"In 1977, the FDA made an attempt to completely ban the substance, following studies showing that the substance caused bladder cancer in rats. The attempted ban was unsuccessful due to public opposition that was encouraged by industry advertisements." ”
- Dados da fonte de
- 2026-06-01
- Acessado
- 2026-07-03 · cópia arquivada
- Cálculo
- Supports the body's historical analogy between the 2023 IARC aspartame classification and the earlier saccharin cancer scare. Congress's Saccharin Study and Labeling Act of 1977 imposed an 18-month moratorium on the FDA's proposed ban and substituted a warning-label requirement instead; the FDA formally withdrew its 1977 ban proposal in 1991. Canada separately removed saccharin from sale as a food additive around 1977 and later lifted that restriction. Neither figure changes this entry's headline no_reliable_estimate status for sweeteners generally — this is background context for the saccharin-specific analogy in the body text, not a claim about artificial sweeteners currently on the market.